Efficacy and safety of the SARS-CoV-2 mRNA vaccine in lung transplant recipients: a possible trigger of rejection

[1]  E. Herzog,et al.  An Acute Exacerbation of Idiopathic Pulmonary Fibrosis After BNT162b2 mRNA COVID-19 Vaccination , 2022, Chest.

[2]  A. Kumanogoh,et al.  Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination , 2022, International Journal of Infectious Diseases.

[3]  T. Luedde,et al.  Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients , 2021, American Journal of Transplantation.

[4]  T. Kalina,et al.  Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein–specific T cells in Lung Transplant Recipients , 2021, Transplantation.

[5]  K. Renaudin,et al.  Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine , 2021, Diabetes & Metabolism.

[6]  A. Gözalan,et al.  Evaluation of antibody response after COVID‐19 vaccination of healthcare workers , 2021, Journal of medical virology.

[7]  J. Fuge,et al.  COVID-19 in lung transplant recipients—Risk prediction and outcomes , 2021, PloS one.

[8]  K. Morita,et al.  Performance of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients: A retrospective study in outbreak on a cruise ship , 2021, PloS one.

[9]  Rebecca F. Halperin,et al.  Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience , 2021, The Journal of Heart and Lung Transplantation.

[10]  R. Higgins,et al.  SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients , 2021, The Journal of Heart and Lung Transplantation.

[11]  A. Haneya,et al.  Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients , 2021, Clinical Research in Cardiology.

[12]  J. Izopet,et al.  Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients , 2021, The New England journal of medicine.

[13]  P. Dormitzer,et al.  Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents , 2021, The New England journal of medicine.

[14]  T. Kalina,et al.  Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients , 2021, The Journal of Heart and Lung Transplantation.

[15]  C. Enestvedt,et al.  Steroid‐Resistant Acute Cellular Rejection of the Liver After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[16]  M. Mehra,et al.  COVID-19 vaccination immune paresis in heart and lung transplantation , 2021, The Journal of Heart and Lung Transplantation.

[17]  D. Segev,et al.  Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. , 2021, JAMA.

[18]  N. Kamar,et al.  Acute rejection after anti–SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant , 2021, Kidney International.

[19]  N. Kamar,et al.  Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney-transplant patient , 2021, Kidney International.

[20]  R. Talotta.  Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” , 2021, Clinical Immunology.

[21]  M. Barrecheguren,et al.  COVID-19 in lung transplant recipients: A multicenter study , 2020, American Journal of Transplantation.

[22]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[23]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[24]  P. Dormitzer,et al.  COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses , 2020, Nature.

[25]  F. D'Ovidio,et al.  COVID-19 in lung transplant recipients: A single center case series from New York City , 2020, American Journal of Transplantation.

[26]  Sharon J Peacock,et al.  Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.

[27]  G. Criner,et al.  COVID‐19 in lung transplant recipients , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[28]  V. Cottin,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review , 2015, Internal and Emergency Medicine.